These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8533277)

  • 61. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
    Brown WC; Palmer GH
    Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The pathogenicity and immunologic relationship of a virulent and a tissue-culture-adapted Babesia bovis.
    Kuttler KL; Zaugg JL; Yunker CE
    Vet Parasitol; 1988 Mar; 27(3-4):239-44. PubMed ID: 3285573
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A conserved motif in the immune-subdominant RAP-1 related antigen of
    Rojas MJ; Bastos RG; Navas J; Laughery JM; Lacy PA; Suarez CE
    Front Immunol; 2024; 15():1380660. PubMed ID: 38720894
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Successful vaccination against Boophilus microplus and Babesia bovis using recombinant antigens.
    Willadsen P; Kemp DH; Cobon GS; Wright IG
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():289-94. PubMed ID: 1343705
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential Bos taurus cattle response to Babesia bovis infection.
    Benavides MV; Sacco AM
    Vet Parasitol; 2007 Nov; 150(1-2):54-64. PubMed ID: 17919816
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transgenic Babesia bovis lacking 6-Cys sexual-stage genes as the foundation for non-transmissible live vaccines against bovine babesiosis.
    Alzan HF; Cooke BM; Suarez CE
    Ticks Tick Borne Dis; 2019 Apr; 10(3):722-728. PubMed ID: 30711475
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cross-protective immunity induced by Babesia bovis clones with antigenically unrelated variable merozoite surface antigens.
    Shkap V; Pipano E; McElwain TF; Herzberg U; Krigel Y; Fish L; Palmer GH
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):367-74. PubMed ID: 7941314
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Babesial antibody dynamics after cattle immunisation with live vaccines, measured with an indirect immunofluorescence test.
    Guglielmone AA; Lugaresi CI; Volpogni MM; Anziani OS; Vanzini VR
    Vet Parasitol; 1997 Jun; 70(1-3):33-9. PubMed ID: 9195707
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular and antigenic characterisation of ribosomal phosphoprotein P0 from Babesia bovis.
    Ramos CA; Araújo FR; Souza II; Oliveira RH; Elisei C; Soares CO; Sacco AM; Rosinha GM; Alves LC
    Mem Inst Oswaldo Cruz; 2009 Nov; 104(7):998-1002. PubMed ID: 20027467
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunity in cattle to Babesia bovis after single infections with parasites of various origin.
    Mahoney DF; Wright IG; Goodger BV
    Aust Vet J; 1979 Jan; 55(1):10-2. PubMed ID: 435202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel 20-kilodalton protein conserved in Babesia bovis and B. bigemina stimulates memory CD4(+) T lymphocyte responses in B. bovis-immune cattle.
    Brown WC; Ruef BJ; Norimine J; Kegerreis KA; Suarez CE; Conley PG; Stich RW; Carson KH; Rice-Ficht AC
    Mol Biochem Parasitol; 2001 Nov; 118(1):97-109. PubMed ID: 11704278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Babesia bovis: identification of immunodominant merozoite surface proteins in soluble culture-derived exoantigen.
    Johnson WC; Perryman LE; Goff WL
    Parasitol Res; 1997; 83(8):776-80. PubMed ID: 9342742
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosis.
    Alzan HF; Bastos RG; Ueti MW; Laughery JM; Rathinasamy VA; Cooke BM; Suarez CE
    Parasit Vectors; 2021 Apr; 14(1):210. PubMed ID: 33879245
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of culture-derived Babesia bovis exoantigen using a two-site enzyme immunoassay.
    Montealegre F; Montenegro-James S; Kakoma I; Ristic M
    J Clin Microbiol; 1987 Sep; 25(9):1648-52. PubMed ID: 3308949
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge.
    Timms P; Barry DN; Gill AC; Sharp PJ; de Vos AJ
    Res Vet Sci; 1988 Sep; 45(2):267-9. PubMed ID: 3194602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Babesia bovis: common protein fractions recognized by oligoclonal B. bovis-specific CD4+ T cell lines from genetically diverse cattle.
    Stich RW; Rice-Ficht AC; Tuo W; Brown WC
    Exp Parasitol; 1999 Jan; 91(1):40-51. PubMed ID: 9920041
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Babesia bovis: bovine helper T cell lines reactive with soluble and membrane antigens of merozoites.
    Brown WC; Logan KS
    Exp Parasitol; 1992 Mar; 74(2):188-99. PubMed ID: 1371257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cell culture-derived Babesia bovis vaccine: sequential challenge exposure of protective immunity during a 6-month postvaccination period.
    Kuttler KL; Levy MG; Ristic M
    Am J Vet Res; 1983 Aug; 44(8):1456-9. PubMed ID: 6354014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of a monoclonal antibody against Babesia bovis merozoite surface antigen-2c for the development of a competitive ELISA test.
    Dominguez M; Zabal O; Wilkowsky S; Echaide I; Torioni de Echaide S; Asenzo G; Rodríguez A; Zamorano P; Farber M; Suarez C; Florin-Christensen M
    Ann N Y Acad Sci; 2004 Oct; 1026():165-70. PubMed ID: 15604488
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.